Safety
-
Metvixia (methyl aminolevulinate HCl) Cream
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
November 2012
ADVERSE REACTIONS
Postmarketing Experience
- angioedema
-
-







